Wednesday, June 10, 2026

biotech Β· Breast Cancer Β· Pleural carcinosis Β· SANA

Sana Biotechnology

Sana Biotechnology clinical programs β€” 19 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

188 E Blaine St, Suite 400, Seattle, Washington 98102, US HQ
2018 Founded
265 Employees
Public company Type
SANA Β· NYSE Ticker
Company details
Status
Public
HQ
188 E Blaine St, Suite 400, Seattle, Washington 98102, US
Founded
2018
Employees
265
Programs
19
Drugs
21
Patents
136
Intelligence Β· Clinical Programs

Sana Biotechnology projects

19 ClinicalTrials.gov programs sponsored by Sana Biotechnology.

Sana Biotechnology has 19 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Sodio ioduro (I131) Curium Netherlands 37-740...

    Sana Biotechnology

    Graves' disease and Graves' orbitophaty

    phase 3 small molecule active

    1 trial
  2. ABC2

    Sana Biotechnology

    Breast Cancer

    phase 2 small molecule active

    1 trial
  3. Dexmedetomidine injection

    Sana Biotechnology

    Post Spinal Shivering

    phase 2 small molecule active

    1 trial
  4. GN-002

    Sana Biotechnology

    Parkinson’s Disease

    phase 2 small molecule active

    1 trial
  5. HCQ01

    Sana Biotechnology

    2019 Novel Coronavirus

    phase 2 small molecule active

    2 trials
  6. Hydroxyurea

    Sana Biotechnology

    Thalassemia, Beta

    phase 2 small molecule active

    1 trial
  7. Myocet (Non-pegylated liposomal doxorubicin (NPLD))

    Sana Biotechnology

    Breast Cancer

    phase 2 small molecule completed

    1 trial
  8. PITAC_ MaPEPi

    Sana Biotechnology

    Pleural carcinosis

    phase 2 small molecule active

    1 trial
  9. TREAT LMNA

    Sana Biotechnology

    Laminopathies

    phase 2 small molecule active

    1 trial
  10. TREDIMIN 25.000 U.I. /2,5 ml soluzione orale

    Sana Biotechnology

    haematologic condition who need staminal cells transplant

    phase 2 small molecule active

    1 trial
  11. Methotrexate

    Sana Biotechnology

    Chronic Plaque Psoriasis

    phase 1 small molecule active

    1 trial
  12. SC262

    Sana Biotechnology

    Non Hodgkin's Lymphoma

    phase 1 small molecule active

    1 trial
  13. SC291

    Sana Biotechnology

    Lupus Erythematosus

    phase 1 mab active

    1 trial
  14. SC291

    Sana Biotechnology

    Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial
  15. UP421

    Sana Biotechnology

    Type1diabetes

    phase 1 mab active

    1 trial
  16. Liraglutide

    Sana Biotechnology

    Morbid Obesity

    approved small molecule completed

    1 trial
  17. TARGET2020

    Sana Biotechnology

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial
  18. Sana Device (Control)

    Sana Biotechnology

    Fibromyalgia

    small molecule terminated

    1 trial
  19. dexmedetomidine

    Sana Biotechnology

    Laparoscopic Cholecystectomy

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Sana Biotechnology have?

19 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.